Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease
暂无分享，去创建一个
Philip Smith | K. Bodger | S. Dodd | S. Subramanian | P. Flanagan | J. Morgan | M. Swaminathan | J. Sabine | T. Townsend | I. Reilly | D. Storey | V. Razanskaite | M. Davies | Christopher Watters | S. Michail | D. Penman | A. Chapman | Violeta Razanskaite | Michael Davies